Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands... Show more
Emerson Electric (EMR) has traded with a steady upward bias in recent weeks, supported by favorable industrial-automation fundamentals and constructive analyst commentary. Over the trailing 30 days, the stock has advanced about 7%, while over the past quarter it has recovered meaningfully from the mid-$130s to trade above $160. The shares have generally held above their 20-day moving average, reflecting improving investor sentiment toward the industrial and process-automation sectors.
Within the market, Emerson is positioned as a beneficiary of long-duration secular themes, including electrification, data-center and grid investment, semiconductor capacity expansion, and liquefied natural gas (LNG) infrastructure. Recent analyst actions have reinforced this view, with several firms initiating or raising coverage with bullish ratings and higher price targets.
Emerson Electric Co. is a global industrial technology and software company headquartered in St. Louis, Missouri. The company delivers automation and software solutions that help customers optimize operations, improve reliability, and accelerate innovation across process, hybrid, and discrete manufacturing environments.
Emerson organizes its business around three primary platforms. Software & Systems includes Control Systems & Software and Test & Measurement, providing industrial software, distributed control systems, and measurement instrumentation. Intelligent Devices encompasses sensors, final control, and measurement devices used across industrial settings. Safety & Productivity provides tools and solutions focused on industrial safety and efficiency.
The company's competitive strengths include a large installed base, a growing recurring-software revenue stream, deep domain expertise across energy and process industries, and exposure to structurally growing end markets. These attributes make EMR a closely followed name for investors seeking exposure to industrial automation and the broader trend of digital transformation in manufacturing.
Several verified developments have shaped investor sentiment toward Emerson over the past month. The most significant was the company's fiscal third-quarter 2026 report, which covered the period ended June 2026. Emerson posted adjusted earnings of $1.71 per share, up 12.5% year over year and ahead of consensus, on revenue of $4.87 billion, an increase of 7%.
Underlying orders rose 7%, and backlog excluding AspenTech increased 7% to $8.2 billion, signaling resilient demand. Software & Systems was the standout, with revenue up 11%, including a 23% gain in Test & Measurement. Management highlighted persistent strength in North America, Japan, India, and Southeast Asia, while Europe and China remained softer.
On the back of these results, Emerson raised its fiscal 2026 guidance, now projecting adjusted earnings per share of approximately $6.55 and free cash flow of about $3.6 billion. Management also pointed to continued momentum in power generation, semiconductors, aerospace and defense, and LNG.
Analyst activity further supported the stock. RBC Capital initiated coverage with an Outperform rating and a $179 price target, later raising that target to $188. Wells Fargo initiated coverage with an Overweight rating and a $177 target, while TD Cowen raised its target to $170. The company also scheduled its fiscal fourth-quarter earnings release for November 4, 2026.
Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots designed to scan and trade across thousands of tickers. While Tickeron offers hundreds of bots, only top-performing and most relevant strategies are featured in this section, making it a useful starting point for traders exploring automated approaches. These bots vary widely in strategy, timeframe, and performance metrics, allowing users to compare signals and identify models that align with their own trading style and risk tolerance. For those interested in applying quantitative, AI-assisted methods to stocks like Emerson Electric, exploring the Trending AI Robots page can provide additional perspective on current market patterns.
Looking ahead, Emerson's fiscal fourth-quarter and full-year results on November 4, 2026, are the most immediate catalyst. Investors will focus on order trends, software annual contract value growth, margin expansion, and management's initial outlook for the upcoming fiscal year.
Beyond earnings, key themes include continued investment in power generation and grid infrastructure, semiconductor and data-center demand, and LNG project activity. Software & Systems momentum, particularly in Test & Measurement and control systems, will remain a central growth driver, while European and Chinese industrial softness represents a potential headwind.
Capital allocation is another area of interest, with management signaling roughly $1 billion in share repurchases and about $1.2 billion in dividends for fiscal 2026. Macroeconomic conditions, interest rates, and broader industrial sector rotation will also influence sentiment. These factors collectively frame the outlook for EMR as investors weigh the durability of its automation-driven growth against a still-uneven global demand environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for EMR turned positive on October 27, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in 32 of 44 cases over the following month. The odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on EMR as a result. In 61 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 217 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 150 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 17 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 17 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.673) is normal, around the industry mean (3.907). P/E Ratio (37.198) is within average values for comparable stocks, (38.471). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.013) settles around the average of (0.030) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of process controls systems, valves and analytical instruments
Industry IndustrialMachinery